DistillerSR Inc. Logo

June 5 2025 • The Royal Sonesta Downtown Minneapolis

Building on the success of Evidence Matters 2024, a virtual Summit that attracted over 1,000 registrants from all corners of the world, DistillerSR’s Evidence Matters Summit goes On the Road in 2025.  The first in-person event of the series was in San Diego. The next edition, in Minneapolis, will bring together experts and pioneers in MedTech, AI, regulatory and copyright compliance, and evidence management. 

This year, we spotlight the transformative power of AI enablement combined with human-in-the-loop validation, showcasing how technology and expert oversight work together to drive efficiency, innovation, and faster time to market. Since 2021, DistillerSR’s Evidence Matters Summits have brought together global leaders in the literature review and evidence-based research community to learn, engage, and address the ever-growing challenges of synthesizing trusted evidence.

Speakers From the Following Companies

Agenda – June 5, 2025

11:30 AM – 12:15 PM
Registration + Networking Lunch
12:20 PM – 2:05 PM

EU MDR Clinical Evaluation Report (CER) Foundations Workshop

Key Objectives
  • Understand the Foundations of a CER: Gain a clear understanding of the purpose and regulatory context of the Clinical Evaluation Report within the MDR framework.
  • Establishing Equivalence: Master the process of claiming equivalence to other devices, including the critical information and justification required to demonstrate safety & performance.
  • Conducting Risk-Benefit Assessment: Master the methodology for conducting a thorough benefit-risk assessment, a crucial component of the CER.
  • Leveraging Clinical Data: Explore various sources of clinical data, including literature reviews, literature search strategies, and manufacturer-generated data. Understand the Notified Body’s expectations for conducting and documenting thorough literature searches.
  • Documenting Clinical Investigations: Gain insights into documenting clinical investigations, including the necessary supporting documentation and understanding the different perspectives of Notified Bodies and Competent Authorities.
  • Considering Post-Market Activities: Understand the link between the CER and post-market clinical follow-up (PMCF) activities and how ongoing data collection informs CER updates.

Speakers

Bassil Akra, CEO at AKRA Team

Lucy Stone, Principal Clinical Evaluation Specialist at BSI

Chip Couch, Learning Specialist at DistillerSR

2:05 PM – 2:50 PM CST

Industry Best Practices Panel – Can AI and Automation Accelerate Regulatory Submissions, Time to Market, and MedTech Innovation?

Key Objectives
  • Understand the existing challenges and bottlenecks in MedTech regulatory submissions, time to market, and innovation processes.
  • Learn how AI and automation can expedite the preparation, review, and submission of regulatory documents, potentially leading to faster approvals.
  • Explore the potential challenges, risks, and ethical considerations associated with using AI in regulatory and innovation processes, such as data bias, security, and the need for human oversight.

Speakers

Angelina Lisandrelli, Director of Regulatory and Quality at RespirTech, a Philips company

Emily Metcalfe, Director, Scientific Communications at Boston Scientific

Peter O’Blenis, CEO at DistillerSR

2:50 PM – 3:00 PM CST

Break

3:00 PM – 4:00 PM CST

Notified Body Roundtable

Key Objectives
  • Understand current interpretations, expectations, and best practices directly from Notified Body representatives regarding critical aspects of the EU MDR and IVDR.
  • Learn about the recurring challenges faced by manufacturers during the conformity assessment process and gain insights into how to proactively address them.
  • Participate in a direct dialogue with Notified Body experts, ask specific questions relevant to your organization, and connect with peers navigating the EU regulatory landscape.

Speakers

Bassil Akra, CEO at AKRA Team
Lucy Stone, Principal Clinical Evaluation Specialist at BSI
Julien Senac, Senior Director, Medical and Health Services Americas at TÜV SÜD
Azam Korshidi, Technical File Reviewer, IVD at DEKRA

4:00 PM – 5:00 PM CST

Standardized Ontologies for Enriched Evidence Data Management

Key Objectives
  • Discover how SciBite uses standardized ontologies to automatically enrich unstructured text with consistent, machine-readable concepts, providing deeper contextual understanding for your evidence data.
  • Learn how DistillerSR integrates with ontologically enriched data to streamline the systematic review process, improving search precision, filtering, and overall workflow efficiency.
  • Understand how the combined power of SciBite and DistillerSR, leveraging standardized ontologies, enhances data accuracy, consistency, and facilitates the discovery of deeper insights from your evidence.

Speakers

Tom Woodcock, Technical Sales Manager at SciBite by Elsevier

Chris Wright, EVP of Operations at DistillerSR

5:00 PM – 6:00 PM CST

Networking Cocktail Hour

Speakers

Bassil Akra

Bassil Akra

CEO at AKRA Team

Lucy Stone

Lucy Stone

Principal Clinical Evaluation Specialist at BSI
Chip Couch

Chip Couch

Learning Specialist at DistillerSR

Angelina Lisandrelli

Angelina Lisandrelli

Director of Regulatory and Quality at RespirTech, a Philips company

Emily Metcalfe

Emily Metcalfe

Director, Scientific Communications at Boston Scientific

Peter O'Blenis

Peter O'Blenis

CEO at DistillerSR

Tom Woodcock

Tom Woodcock

Technical Sales Manager at  SciBite by Elsevier

Chris Wright

Chris Wright

EVP of Operations at DistillerSR

Julien Senac

Julien Senac

Senior Director, Medical and Health Services Americas at TÜV SÜD

Azam Korshidi

Azam Korshidi

Technical File Reviewer,
IVD at DEKRA

EM’24 in Review

1117

registrants

580

attendees across Medical Devices/IVD, Pharmaceuticals, Public Sector, and Academia

34

Speakers from Philips, Adelphi Group, AbbVie, Stryker, PHAC, EPA, ISPOR, QuidelOrtho, OPEN Health, and CDC

4/5

Average Satisfaction Score

“Excellent seminar, definitely worth my time!"

– Medical Devices Industry Session, Carl Zeiss

“Exceptional panel discussion on Medical Devices."

– Medical Devices Industry Session, Stryker

“Insightful and crisp session. Thank you for an amazing hour."

– Keynote Day Two, Orcimed

“Great Notified Body Webinar."

– NB Partner Session, Microport

“It was a really interesting topic. I am interested to learn more about Evidence Diversity and Integrity (EDI)"

– Keynote Day One, Integra LifeSciences

“I am very excited to attend this event again in 2025. It was amazing last year. I have not stopped sharing my learnings from EM 24 with my colleagues. I am also excited that more people from the Boston Scientific Endoscopy team will be joining."

Brent Rivard, Clinical Risk Manager at Boston Scientific.